Continuity of Care: Pneumonia: Targeting Treatments and Monitoring the Response
November 1st 2008Pneumonia and influenza together represent the seventh leading cause of death in the United States. Pharmacists can influence care by ensuring that appropriate therapy is initiated quickly and closely monitoring patients.
Read More
PEP for HIV, Hepatitis B, and Hepatitis C May Reduce Risk
August 1st 2007Dr. Grandinetti is a senior clinical research pharmacist at the National Cancer Institute, National Institutes of Health, Rockville, Md. The views expressed are those of the author and not those of any government agency.
Read More